Leadership Overview
A*STAR has 5 executives leading key functions including strategy, operations, technology, risk management, and talent development.
Driven by scientific discovery, A*STAR advances technology through open innovation, collaborating with public and private sectors to foster economic growth, create jobs, and enhance societal well-being in healthcare, urban living, and sustainability.
Driven by scientific discovery, A*STAR advances technology through open innovation, collaborating with public and private sectors to foster economic growth, create jobs, and enhance societal well-being in healthcare, urban living, and sustainability.
Leadership Roles at A*STAR
Fakhar Hassan - Chief Executive Officer
Fakhar Hassan, the Chief Executive Officer at A*STAR, directs the agency's overarching strategy for economic-oriented research and technological advancement. Hassan guides the organization's mission to bridge academia and industry, ensuring research outputs translate into tangible economic growth and job creation for Singapore. This leadership role involves setting the vision for A*STAR's R&D activities across biomedical sciences and physical sciences and engineering. Fakhar Hassan oversees the cultivation of talent within the agency, the broader research community, and industry partners, fostering a diverse pipeline of leaders. The Chief Executive Officer's focus remains on maximizing societal benefits through improved healthcare, urban living, and sustainability initiatives, driving innovation from Singapore's research hubs in Biopolis and Fusionopolis.
Yee-Chia Yeo - Deputy Chief Executive Officer
Yee-Chia Yeo, the Deputy Chief Executive Officer at A*STAR, executes operational strategies that support the agency's mandate for scientific discovery and technological innovation. Yeo works closely with the Chief Executive Officer to ensure seamless collaboration between A*STAR's research entities and industry partners, facilitating the transition of research findings into commercial applications. The Deputy Chief Executive Officer oversees the day-to-day management of A*STAR's diverse R&D portfolio, spanning biomedical sciences and physical sciences and engineering. Yee-Chia Yeo plays a critical part in nurturing talent and developing leaders across the agency and the wider ecosystem, contributing to Singapore's economic growth and societal well-being. This role is central to maintaining A*STAR's position as a bridge between academic research and industrial implementation.
Teresa Ho - President of ASTAR Postdoc and Early Career Scientist Society (APECSS)
Teresa Ho, the President of ASTAR Postdoc and Early Career Scientist Society (APECSS) at A*STAR, champions the development and support of emerging scientific talent within the agency. Ho leads initiatives focused on professional growth, networking, and career advancement for postdoctoral researchers and early-career scientists across A*STAR's R&D entities. This role is integral to nurturing the next generation of leaders in biomedical sciences and physical sciences and engineering, ensuring a vibrant research ecosystem. Teresa Ho advocates for the needs of early-career researchers, fostering an environment conducive to innovation and scientific discovery. The President of A*STAR Postdoc and Early Career Scientist Society (APECSS) contributes to A*STAR's broader mission of bridging academia and industry by empowering future scientific leaders who will drive economic growth and societal benefits for Singapore.
Wei-Seng Kan - Chief Information Officer
Wei-Seng Kan, the Chief Information Officer at A*STAR, architects and manages the agency's information technology infrastructure and digital strategy. Kan ensures that A*STAR's technological backbone supports its core mission of advancing scientific discovery and developing innovative technologies across biomedical sciences and physical sciences and engineering. This leadership position involves overseeing the implementation of robust IT systems that facilitate collaboration, data management, and operational efficiency for researchers in Biopolis and Fusionopolis. Wei-Seng Kan drives the digital transformation initiatives, enabling A*STAR to effectively bridge the gap between academia and industry. The Chief Information Officer's responsibilities extend to safeguarding sensitive research data and ensuring compliance with relevant regulations, thereby supporting Singapore's economic growth and societal benefits.
Philip Feng - Chief Risk Officer & Chief Revenue Officer
Philip Feng, the Chief Risk Officer & Chief Revenue Officer at A*STAR, directs the strategic management of financial risks and spearheads revenue generation initiatives. Feng ensures A*STAR's financial stability and operational resilience by implementing comprehensive risk mitigation frameworks across its diverse research activities in biomedical sciences and physical sciences and engineering. Simultaneously, the Chief Revenue Officer drives efforts to commercialize research outcomes, forging partnerships that translate scientific advancements into economic value for Singapore. Philip Feng's dual role is critical in balancing prudent financial oversight with aggressive pursuit of market opportunities, supporting the agency's mission to bridge academia and industry. This leadership ensures that A*STAR's contributions to healthcare, urban living, and sustainability are financially sustainable and impactful.
Explore Leadership Teams in Business Services
Founded in 1828, Bureau Veritas is an international certification agency. The company operates through the following businesses: Marine and Offshore, Industry, In-Service Inspection and Verification, Construction, Certification, Commodities, Consumer Products, and Government Services and International Trade. Bureau Veritas is based in France.
Company Leadership MB

AK
Founded in 2002 and headquartered in Piscataway, New Jersey, Genscript is the worlds leading biotech company providing life sciences services and products. The company has four platforms including leading life-science services and products platform to provide one-stop solutions to global research communities, a biologics contract development and manufacturing organization (the "CDMO") platform, an industrial synthetic products platform, and an integrated global cell therapy platform.
Company Leadership JZ
SW
RC
LW
Ascential Technologies delivers design, development and manufacturing solutions that tackle the toughest problems, unlocking performance for mission-critical companies. With global scale, deep expertise and practical know-how born from seven decades on the cutting edge of automation, Ascential partners with customers every step of the way to accelerate and realize their innovations. We deliver a range of offerings, from the most complex diagnostic tools used in life sciences, to the development and testing of adaptive safety systems in electric vehicles, to the inspection of advanced microprocessors for functional integrity and much more. Through our diverse portfolio of solutions, Ascential helps customers accelerate their innovation, mitigate risk, drive competitive differentiation, and reduce time to market at scale.
Company Leadership
GD
DB
SO
Founded in 1985, Pharmaceutical Product Development (PPD) is a contract research organization engaging in drug discovery, development and lifecycle management for clients from pharmaceutical, biotechnological, medical device, academic and government organizations.
Company Leadership LE
FS
MW
